12 results on '"Rehberg T"'
Search Results
2. Reference point insensitive molecular data analysis
- Author
-
Altenbuchinger, M, primary, Rehberg, T, additional, Zacharias, H U, additional, Stämmler, F, additional, Dettmer, K, additional, Weber, D, additional, Hiergeist, A, additional, Gessner, A, additional, Holler, E, additional, Oefner, P J, additional, and Spang, R, additional
- Published
- 2016
- Full Text
- View/download PDF
3. Reference point insensitive molecular data analysis.
- Author
-
Altenbuchinger, M., Rehberg, T., Zacharias, H. U., Stämmler, F., Dettmer, K., Weber, D., Hiergeist, A., Gessner, A., Holler, E., Oefner, P. J., and Spang, R.
- Subjects
- *
GENE expression , *MOLECULAR genetics , *BLOOD cells , *BIOINFORMATICS , *METABOLOMICS - Abstract
Motivation: In biomedicine, every molecular measurement is relative to a reference point, like a fixed aliquot of RNA extracted from a tissue, a defined number of blood cells, or a defined volume of biofluid. Reference points are often chosen for practical reasons. For example, we might want to assess the metabolome of a diseased organ but can only measure metabolites in blood or urine. In this case, the observable data only indirectly reflects the disease state. The statistical implications of these discrepancies in reference points have not yet been discussed. Results: Here, we show that reference point discrepancies compromise the performance of regression models like the LASSO. As an alternative, we suggest zero-sum regression for a reference point insensitive analysis. We show that zero-sum regression is superior to the LASSO in case of a poor choice of reference point both in simulations and in an application that integrates intestinal microbiome analysis with metabolomics. Moreover, we describe a novel coordinate descent based algorithm to fit zero-sum elastic nets. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
4. Ueber mangelhafte arterielle Blutversorgung des Gehirns und der oberen Extremitäten bei Aneurysma arcus aortae
- Author
-
Rehberg, T.-H.
- Abstract
n/a
- Published
- 1908
5. Feasibility of using real-world free thyroxine data from the US and Europe to enable fast and efficient transfer of reference intervals from one population to another.
- Author
-
Kurka H, Dilba P, Perez CC, Findeisen P, Gironés IG, Katayev A, Alonso LR, Valcour A, Rehberg T, Weber B, Donner H, and Thorenz A
- Abstract
Objectives: The direct approach for determining reference intervals (RIs) is not always practical. This study aimed to generate evidence that a real-world data (RWD) approach could be applied to transfer free thyroxine RIs determined in one population to a second population, presenting an alternative to performing multiple RI determinations., Design and Methods: Two datasets (US, n = 10,000; Europe, n = 10,000) were created from existing RWD. Descriptive statistics, density plots and cumulative distributions were produced for each data set and comparisons made. Cumulative probabilities at the lower and upper limits of the RIs were identified using an empirical cumulative distribution function. According to these probabilities, estimated percentiles for each dataset and estimated differences between the two sets of percentiles were obtained by case resampling bootstrapping. The estimated differences were then evaluated against a pre-determined acceptance criterion of ≤7.8% (inter-individual biological variability). The direct approach was used to validate the RWD approach., Results: The RWD approach provided similar descriptive statistics for both populations (mean: US = 16.1 pmol/L, Europe = 16.4 pmol/L; median: US = 15.4 pmol/L, Europe = 15.8 pmol/L). Differences between the estimated percentiles at the upper and lower limits of the RIs fulfilled the pre-determined acceptance criterion and the density plots and cumulative distributions demonstrated population homogeneity. Similar RI distributions were observed using the direct approach., Conclusions: This study provides evidence that a RWD approach can be used to transfer RIs determined in one population to another., Competing Interests: Hedwig Kurka, Peter Dilba, Thorsten Rehberg, Benedikt Weber, Horst Donner and Anja Thorenz are employees of Roche Diagnostics GmbH. Alex Katayev and André Valcour are employees of Laboratory Corporation of America Holdings (Labcorp). Ignacio Gadea Gironés, Carlos Castillo Perez, Peter Findeisen and Laura Rodríguez Alonso have no conflict of interest to declare., (© 2024 The Authors.)
- Published
- 2024
- Full Text
- View/download PDF
6. Gene expression-based outcome prediction in advanced stage classical Hodgkin lymphoma treated with BEACOPP.
- Author
-
Jachimowicz RD, Klapper W, Glehr G, Müller H, Haverkamp H, Thorns C, Hansmann ML, Möller P, Stein H, Rehberg T, von Tresckow B, Reinhardt HC, Borchmann P, Chan FC, Spang R, Scott DW, Engert A, Steidl C, Altenbuchinger M, and Rosenwald A
- Subjects
- Adolescent, Adult, Bleomycin therapeutic use, Chemokine CCL17 genetics, Chemokine CCL17 metabolism, Cyclophosphamide therapeutic use, Doxorubicin therapeutic use, Etoposide therapeutic use, Female, Gene Expression Profiling methods, Hodgkin Disease genetics, Humans, Ki-1 Antigen genetics, Ki-1 Antigen metabolism, Male, Middle Aged, Neoplasm Staging, Predictive Value of Tests, Prednisone therapeutic use, Procarbazine therapeutic use, Receptor, Platelet-Derived Growth Factor alpha genetics, Receptor, Platelet-Derived Growth Factor alpha metabolism, Survival Rate, Transcriptome, Treatment Outcome, Vincristine therapeutic use, Young Adult, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Hodgkin Disease drug therapy, Hodgkin Disease pathology
- Published
- 2021
- Full Text
- View/download PDF
7. High CD206 levels in Hodgkin lymphoma-educated macrophages are linked to matrix-remodeling and lymphoma dissemination.
- Author
-
Arlt A, von Bonin F, Rehberg T, Perez-Rubio P, Engelmann JC, Limm K, Reinke S, Dullin C, Sun X, Specht R, Maulhardt M, Linke F, Bunt G, Klapper W, Vockerodt M, Wilting J, Pukrop T, Dettmer K, Gronwald W, Oefner PJ, Spang R, and Kube D
- Subjects
- Animals, Antigens, CD metabolism, Antigens, Differentiation, Myelomonocytic metabolism, B7-H1 Antigen metabolism, CD40 Antigens metabolism, Cell Differentiation drug effects, Cell Line, Tumor, Chick Embryo, Chorioallantoic Membrane metabolism, Chorioallantoic Membrane pathology, Collagen Type I metabolism, Culture Media, Conditioned metabolism, Fluorescent Antibody Technique, Hodgkin Disease immunology, Hodgkin Disease pathology, Humans, Interleukin-13 metabolism, Lymphoma, B-Cell immunology, Lymphoma, B-Cell pathology, Macrophages drug effects, Membrane Glycoproteins immunology, Monocytes metabolism, Neoplasm Metastasis immunology, Proteome genetics, Proteome metabolism, RNA-Seq, Receptors, Cell Surface metabolism, Receptors, Immunologic immunology, Up-Regulation, Xenograft Model Antitumor Assays, Culture Media, Conditioned pharmacology, Hodgkin Disease metabolism, Lymphoma, B-Cell metabolism, Macrophages metabolism, Membrane Glycoproteins metabolism, Receptors, Immunologic metabolism, Tumor Microenvironment
- Abstract
Macrophages (Mφ) are abundantly present in the tumor microenvironment and may predict outcome in solid tumors and defined lymphoma subtypes. Mφ heterogeneity, the mechanisms of their recruitment, and their differentiation into lymphoma-promoting, alternatively activated M2-like phenotypes are still not fully understood. Therefore, further functional studies are required to understand biological mechanisms associated with human tumor-associated Mφ (TAM). Here, we show that the global mRNA expression and protein abundance of human Mφ differentiated in Hodgkin lymphoma (HL)-conditioned medium (CM) differ from those of Mφ educated by conditioned media from diffuse large B-cell lymphoma (DLBCL) cells or, classically, by macrophage colony-stimulating factor (M-CSF). Conditioned media from HL cells support TAM differentiation through upregulation of surface antigens such as CD40, CD163, CD206, and PD-L1. In particular, RNA and cell surface protein expression of mannose receptor 1 (MRC1)/CD206 significantly exceed the levels induced by classical M-CSF stimulation in M2-like Mφ; this is regulated by interleukin 13 to a large extent. Functionally, high CD206 enhances mannose-dependent endocytosis and uptake of type I collagen. Together with high matrix metalloprotease9 secretion, HL-TAMs appear to be active modulators of the tumor matrix. Preclinical in ovo models show that co-cultures of HL cells with monocytes or Mφ support dissemination of lymphoma cells via lymphatic vessels, while tumor size and vessel destruction are decreased in comparison with lymphoma-only tumors. Immunohistology of human HL tissues reveals a fraction of cases feature large numbers of CD206-positive cells, with high MRC1 expression being characteristic of HL-stage IV. In summary, the lymphoma-TAM interaction contributes to matrix-remodeling and lymphoma cell dissemination., (© 2019 The Authors. Published by FEBS Press and John Wiley & Sons Ltd.)
- Published
- 2020
- Full Text
- View/download PDF
8. Cooperative STAT/NF-κB signaling regulates lymphoma metabolic reprogramming and aberrant GOT2 expression.
- Author
-
Feist M, Schwarzfischer P, Heinrich P, Sun X, Kemper J, von Bonin F, Perez-Rubio P, Taruttis F, Rehberg T, Dettmer K, Gronwald W, Reinders J, Engelmann JC, Dudek J, Klapper W, Trümper L, Spang R, Oefner PJ, and Kube D
- Subjects
- Aspartate Aminotransferase, Mitochondrial metabolism, B-Lymphocytes metabolism, Cell Line, Tumor, Cell Proliferation genetics, Cell Transformation, Neoplastic genetics, Cellular Reprogramming genetics, Cohort Studies, Female, Humans, Lymphoma, Large B-Cell, Diffuse mortality, Lymphoma, Large B-Cell, Diffuse pathology, Male, Phosphorylation, Prognosis, Promoter Regions, Genetic genetics, Proto-Oncogene Proteins c-myc genetics, Proto-Oncogene Proteins c-myc metabolism, Signal Transduction genetics, Survival Analysis, Aspartate Aminotransferase, Mitochondrial genetics, Gene Expression Regulation, Neoplastic, Lymphoma, Large B-Cell, Diffuse genetics, STAT3 Transcription Factor metabolism, Transcription Factor RelA metabolism
- Abstract
Knowledge of stromal factors that have a role in the transcriptional regulation of metabolic pathways aside from c-Myc is fundamental to improvements in lymphoma therapy. Using a MYC-inducible human B-cell line, we observed the cooperative activation of STAT3 and NF-κB by IL10 and CpG stimulation. We show that IL10 + CpG-mediated cell proliferation of MYC
low cells depends on glutaminolysis. By13 C- and15 N-tracing of glutamine metabolism and metabolite rescue experiments, we demonstrate that GOT2 provides aspartate and nucleotides to cells with activated or aberrant Jak/STAT and NF-κB signaling. A model of GOT2 transcriptional regulation is proposed, in which the cooperative phosphorylation of STAT3 and direct joint binding of STAT3 and p65/NF-κB to the proximal GOT2 promoter are important. Furthermore, high aberrant GOT2 expression is prognostic in diffuse large B-cell lymphoma underscoring the current findings and importance of stromal factors in lymphoma biology.- Published
- 2018
- Full Text
- View/download PDF
9. Scale-Invariant Biomarker Discovery in Urine and Plasma Metabolite Fingerprints.
- Author
-
Zacharias HU, Rehberg T, Mehrl S, Richtmann D, Wettig T, Oefner PJ, Spang R, Gronwald W, and Altenbuchinger M
- Subjects
- Humans, Magnetic Resonance Spectroscopy, Algorithms, Biomarkers blood, Biomarkers urine, Metabolomics
- Abstract
Metabolomics data is typically scaled to a common reference like a constant volume of body fluid, a constant creatinine level, or a constant area under the spectrum. Such scaling of the data, however, may affect the selection of biomarkers and the biological interpretation of results in unforeseen ways. Here, we studied how both the outcome of hypothesis tests for differential metabolite concentration and the screening for multivariate metabolite signatures are affected by the choice of scale. To overcome this problem for metabolite signatures and to establish a scale-invariant biomarker discovery algorithm, we extended linear zero-sum regression to the logistic regression framework and showed in two applications to
1 H NMR-based metabolomics data how this approach overcomes the scaling problem. Logistic zero-sum regression is available as an R package as well as a high-performance computing implementation that can be downloaded at https://github.com/rehbergT/zeroSum .- Published
- 2017
- Full Text
- View/download PDF
10. Cell-of-origin classification by gene expression and MYC-rearrangements in diffuse large B-cell lymphoma of children and adolescents.
- Author
-
Szczepanowski M, Lange J, Kohler CW, Masque-Soler N, Zimmermann M, Aukema SM, Altenbuchinger M, Rehberg T, Mahn F, Siebert R, Spang R, Burkhardt B, and Klapper W
- Subjects
- Adolescent, Biomarkers, Tumor, Child, Child, Preschool, Cohort Studies, Female, Humans, Male, Recurrence, Clonal Evolution genetics, Gene Expression, Lymphoma, Large B-Cell, Diffuse diagnosis, Lymphoma, Large B-Cell, Diffuse genetics, Proto-Oncogene Proteins c-myc genetics, Translocation, Genetic
- Abstract
We present the largest series of diffuse large B-cell lymphoma (DLBCL) in patients younger than 18 years analysed to date by gene expression profiling using Nanostring technology to identify molecular subtypes and fluorescent in situ hybridization for translocations of MYC. We show that the activated B cell-like subtype of DLBCL is exceedingly rare in children and - in contrast to adults- not associated with outcome. Furthermore, we review the current literature and demonstrate that MYC translocations are not more frequent in paediatric compared to adult DLBCL. A prognostic role of MYC in the paediatric age groups seems unlikely., (© 2017 John Wiley & Sons Ltd.)
- Published
- 2017
- Full Text
- View/download PDF
11. Measuring critical transitions in financial markets.
- Author
-
Jurczyk J, Rehberg T, Eckrot A, and Morgenstern I
- Abstract
Tipping points in complex systems are structural transitions from one state to another. In financial markets these critical points are connected to systemic risks, which have led to financial crisis in the past. Due to this, researchers are studying tipping points with different methods. This paper introduces a new method which bridges the gap between real-world portfolio management and statistical facts in financial markets in order to give more insight into the mechanics of financial markets.
- Published
- 2017
- Full Text
- View/download PDF
12. Synergy of interleukin 10 and toll-like receptor 9 signalling in B cell proliferation: Implications for lymphoma pathogenesis.
- Author
-
Feist M, Kemper J, Taruttis F, Rehberg T, Engelmann JC, Gronwald W, Hummel M, Spang R, and Kube D
- Subjects
- B-Lymphocytes cytology, Cell Division, Cell Line, Transformed, Cell Transformation, Neoplastic, Cells, Cultured, CpG Islands, Cyclin-Dependent Kinase 4 antagonists & inhibitors, Cyclin-Dependent Kinase 4 physiology, Cyclin-Dependent Kinase 6 antagonists & inhibitors, Cyclin-Dependent Kinase 6 physiology, Drug Synergism, Gene Expression Regulation, Humans, Interleukin-10 pharmacology, Lymphoma etiology, Proto-Oncogene Proteins c-myc physiology, S Phase drug effects, STAT3 Transcription Factor metabolism, Signal Transduction drug effects, Signal Transduction physiology, Toll-Like Receptor 9 agonists, Transcription Factor RelA metabolism, B-Lymphocytes drug effects, Interleukin-10 physiology, Toll-Like Receptor 9 physiology
- Abstract
A network of autocrine and paracrine signals defines B cell homeostasis and is thought to be involved in transformation processes. Investigating interactions of these microenvironmental factors and their relation to proto-oncogenes as c-Myc (MYC) is fundamental to understand the biology of B cell lymphoma. Therefore, B cells with conditional MYC expression were stimulated with CD40L, insulin-like growth factor 1, α-IgM, Interleukin-10 (IL10) and CpG alone or in combination. The impact of forty different interventions on cell proliferation was investigated in MYC deprived cells and calculated by linear regression. Combination of CpG and IL10 led to a strong synergistic activation of cell proliferation (S-phase/doubling of total cell number) comparable to cells with high MYC expression. A synergistic up-regulation of CDK4, CDK6 and CCND3 expression by IL10 and CpG treatment was causal for this proliferative effect as shown by qRT-PCR analysis and inhibition of the CDK4/6 complex by PD0332991. Furthermore, treatment of stimulated MYC deprived cells with MLN120b, ACHP, Pyridone 6 or Ruxolitinib showed that IL10/CpG induced proliferation and CDK4 expression were JAK/STAT3 and IKK/NF-κB dependent. This was further supported by STAT3 and p65/RELA knockdown experiments, showing strongest effects on cell proliferation and CDK4 expression after double knockdown. Additionally, chromatin immunoprecipitation revealed a dual binding of STAT3 and p65 to the proximal promotor of CDK4 after IL10/CpG treatment. Therefore, the observed synergism of IL10R and TLR9 signalling was able to induce proliferation in a comparable way as aberrant MYC and might play a role in B cell homeostasis or transformation., (© 2016 UICC.)
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.